BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Marroqui L, Perez-Serna AA, Babiloni-Chust I, Dos Santos RS. Type I interferons as key players in pancreatic β-cell dysfunction in type 1 diabetes. Int Rev Cell Mol Biol 2021;359:1-80. [PMID: 33832648 DOI: 10.1016/bs.ircmb.2021.02.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Isaacs SR, Foskett DB, Maxwell AJ, Ward EJ, Faulkner CL, Luo JYX, Rawlinson WD, Craig ME, Kim KW. Viruses and Type 1 Diabetes: From Enteroviruses to the Virome. Microorganisms 2021;9:1519. [PMID: 34361954 DOI: 10.3390/microorganisms9071519] [Reference Citation Analysis]
2 Pol J, Paillet J, Plantureux C, Kroemer G. Beneficial autoimmunity and maladaptive inflammation shape epidemiological links between cancer and immune-inflammatory diseases. OncoImmunology 2022;11:2029299. [DOI: 10.1080/2162402x.2022.2029299] [Reference Citation Analysis]
3 Strober W. Treatment of Type 1 Diabetes by Microbiome Maintenance. Gastroenterology 2022;162:1042-4. [PMID: 35065984 DOI: 10.1053/j.gastro.2022.01.018] [Reference Citation Analysis]
4 Nigi L, Brusco N, Grieco GE, Fignani D, Licata G, Formichi C, Aiello E, Marselli L, Marchetti P, Krogvold L, Jorgensen KD, Sebastiani G, Dotta F. Increased Expression of Viral Sensor MDA5 in Pancreatic Islets and in Hormone-Negative Endocrine Cells in Recent Onset Type 1 Diabetic Donors. Front Immunol 2022;13:833141. [DOI: 10.3389/fimmu.2022.833141] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]